PSA vs STE · rev $4.82B vs P/E 25, rev $5.46B
PSA (PSA) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
PSA (PSA) common stock.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
PSA currently screens at market cap $0. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the PSA and STE stock pages for the full models.
Not investment advice.